A high mucosal blocking score is associated with HIV protection

Alexandre Girard, Norma Rallón, José M. Benito, Fabienne Jospin, Carmen Rodriguez, Blandine Chanut, Fahd Benjelloun, Jorge Del Romero, Bernard Verrier, Frédéric Lucht, Jean Jacques Pin, Christian Genin, Mara Biasin, Mario Clerici, Stéphane Paul

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Early steps of HIV infection are mediated by the binding of the envelope to mucosal receptors as α4β7 and the C-type lectins DC-SIGN and langerin. Previously Env-specific B-cell responses have been reported in highly exposed seronegative individuals (HESN). METHOD: Here, we studied gp120-specific antibodies ability to block HIV interaction with α4β7, DC-SIGN and/or langerinin HESN. New cell-based assays were developed to analyze whether antibodies that can alter gp120 binding to α4β7, DC-SIGN and/or langerin are induced in HESN. A mucosal blocking score (MBS) was defined based on the ability of antibodies to interfere with gp120/α4β7, gp120/DC-SIGN, and gp120/langerin binding. A new MBS was evaluated in a cohort of 86 HESN individuals and compared with HIV patients or HIV unexposed healthy individuals. RESULTS: Antibodies reducing gp120 binding to both α4β7 and DC-SIGN were present in HESN serum but also in mucosal secretions, whereas antibodies from HIV patients facilitated gp120 binding to DC-SIGN. Any correlation was observed between MBS and the capacity of antibodies to neutralize infection of α4β7 CD4 T cells with primary isolates. CONCLUSIONS: MBS is significantly associated with protection in HESN and might reflect altered HIV spreading to mucosal-associated lymphoid tissues.

Original languageEnglish
Pages (from-to)411-423
Number of pages13
JournalAIDS (London, England)
Volume33
Issue number3
DOIs
Publication statusPublished - Mar 1 2019

Fingerprint

HIV
Antibodies
C-Type Lectins
HIV Antibodies
Lymphoid Tissue
HIV Infections
DC-specific ICAM-3 grabbing nonintegrin
B-Lymphocytes
T-Lymphocytes
Infection
Serum

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Girard, A., Rallón, N., Benito, J. M., Jospin, F., Rodriguez, C., Chanut, B., ... Paul, S. (2019). A high mucosal blocking score is associated with HIV protection. AIDS (London, England), 33(3), 411-423. https://doi.org/10.1097/QAD.0000000000002099

A high mucosal blocking score is associated with HIV protection. / Girard, Alexandre; Rallón, Norma; Benito, José M.; Jospin, Fabienne; Rodriguez, Carmen; Chanut, Blandine; Benjelloun, Fahd; Del Romero, Jorge; Verrier, Bernard; Lucht, Frédéric; Pin, Jean Jacques; Genin, Christian; Biasin, Mara; Clerici, Mario; Paul, Stéphane.

In: AIDS (London, England), Vol. 33, No. 3, 01.03.2019, p. 411-423.

Research output: Contribution to journalArticle

Girard, A, Rallón, N, Benito, JM, Jospin, F, Rodriguez, C, Chanut, B, Benjelloun, F, Del Romero, J, Verrier, B, Lucht, F, Pin, JJ, Genin, C, Biasin, M, Clerici, M & Paul, S 2019, 'A high mucosal blocking score is associated with HIV protection', AIDS (London, England), vol. 33, no. 3, pp. 411-423. https://doi.org/10.1097/QAD.0000000000002099
Girard A, Rallón N, Benito JM, Jospin F, Rodriguez C, Chanut B et al. A high mucosal blocking score is associated with HIV protection. AIDS (London, England). 2019 Mar 1;33(3):411-423. https://doi.org/10.1097/QAD.0000000000002099
Girard, Alexandre ; Rallón, Norma ; Benito, José M. ; Jospin, Fabienne ; Rodriguez, Carmen ; Chanut, Blandine ; Benjelloun, Fahd ; Del Romero, Jorge ; Verrier, Bernard ; Lucht, Frédéric ; Pin, Jean Jacques ; Genin, Christian ; Biasin, Mara ; Clerici, Mario ; Paul, Stéphane. / A high mucosal blocking score is associated with HIV protection. In: AIDS (London, England). 2019 ; Vol. 33, No. 3. pp. 411-423.
@article{b1d83a8e95454116a2aebcc114af3cef,
title = "A high mucosal blocking score is associated with HIV protection",
abstract = "BACKGROUND: Early steps of HIV infection are mediated by the binding of the envelope to mucosal receptors as α4β7 and the C-type lectins DC-SIGN and langerin. Previously Env-specific B-cell responses have been reported in highly exposed seronegative individuals (HESN). METHOD: Here, we studied gp120-specific antibodies ability to block HIV interaction with α4β7, DC-SIGN and/or langerinin HESN. New cell-based assays were developed to analyze whether antibodies that can alter gp120 binding to α4β7, DC-SIGN and/or langerin are induced in HESN. A mucosal blocking score (MBS) was defined based on the ability of antibodies to interfere with gp120/α4β7, gp120/DC-SIGN, and gp120/langerin binding. A new MBS was evaluated in a cohort of 86 HESN individuals and compared with HIV patients or HIV unexposed healthy individuals. RESULTS: Antibodies reducing gp120 binding to both α4β7 and DC-SIGN were present in HESN serum but also in mucosal secretions, whereas antibodies from HIV patients facilitated gp120 binding to DC-SIGN. Any correlation was observed between MBS and the capacity of antibodies to neutralize infection of α4β7 CD4 T cells with primary isolates. CONCLUSIONS: MBS is significantly associated with protection in HESN and might reflect altered HIV spreading to mucosal-associated lymphoid tissues.",
author = "Alexandre Girard and Norma Rall{\'o}n and Benito, {Jos{\'e} M.} and Fabienne Jospin and Carmen Rodriguez and Blandine Chanut and Fahd Benjelloun and {Del Romero}, Jorge and Bernard Verrier and Fr{\'e}d{\'e}ric Lucht and Pin, {Jean Jacques} and Christian Genin and Mara Biasin and Mario Clerici and St{\'e}phane Paul",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/QAD.0000000000002099",
language = "English",
volume = "33",
pages = "411--423",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - A high mucosal blocking score is associated with HIV protection

AU - Girard, Alexandre

AU - Rallón, Norma

AU - Benito, José M.

AU - Jospin, Fabienne

AU - Rodriguez, Carmen

AU - Chanut, Blandine

AU - Benjelloun, Fahd

AU - Del Romero, Jorge

AU - Verrier, Bernard

AU - Lucht, Frédéric

AU - Pin, Jean Jacques

AU - Genin, Christian

AU - Biasin, Mara

AU - Clerici, Mario

AU - Paul, Stéphane

PY - 2019/3/1

Y1 - 2019/3/1

N2 - BACKGROUND: Early steps of HIV infection are mediated by the binding of the envelope to mucosal receptors as α4β7 and the C-type lectins DC-SIGN and langerin. Previously Env-specific B-cell responses have been reported in highly exposed seronegative individuals (HESN). METHOD: Here, we studied gp120-specific antibodies ability to block HIV interaction with α4β7, DC-SIGN and/or langerinin HESN. New cell-based assays were developed to analyze whether antibodies that can alter gp120 binding to α4β7, DC-SIGN and/or langerin are induced in HESN. A mucosal blocking score (MBS) was defined based on the ability of antibodies to interfere with gp120/α4β7, gp120/DC-SIGN, and gp120/langerin binding. A new MBS was evaluated in a cohort of 86 HESN individuals and compared with HIV patients or HIV unexposed healthy individuals. RESULTS: Antibodies reducing gp120 binding to both α4β7 and DC-SIGN were present in HESN serum but also in mucosal secretions, whereas antibodies from HIV patients facilitated gp120 binding to DC-SIGN. Any correlation was observed between MBS and the capacity of antibodies to neutralize infection of α4β7 CD4 T cells with primary isolates. CONCLUSIONS: MBS is significantly associated with protection in HESN and might reflect altered HIV spreading to mucosal-associated lymphoid tissues.

AB - BACKGROUND: Early steps of HIV infection are mediated by the binding of the envelope to mucosal receptors as α4β7 and the C-type lectins DC-SIGN and langerin. Previously Env-specific B-cell responses have been reported in highly exposed seronegative individuals (HESN). METHOD: Here, we studied gp120-specific antibodies ability to block HIV interaction with α4β7, DC-SIGN and/or langerinin HESN. New cell-based assays were developed to analyze whether antibodies that can alter gp120 binding to α4β7, DC-SIGN and/or langerin are induced in HESN. A mucosal blocking score (MBS) was defined based on the ability of antibodies to interfere with gp120/α4β7, gp120/DC-SIGN, and gp120/langerin binding. A new MBS was evaluated in a cohort of 86 HESN individuals and compared with HIV patients or HIV unexposed healthy individuals. RESULTS: Antibodies reducing gp120 binding to both α4β7 and DC-SIGN were present in HESN serum but also in mucosal secretions, whereas antibodies from HIV patients facilitated gp120 binding to DC-SIGN. Any correlation was observed between MBS and the capacity of antibodies to neutralize infection of α4β7 CD4 T cells with primary isolates. CONCLUSIONS: MBS is significantly associated with protection in HESN and might reflect altered HIV spreading to mucosal-associated lymphoid tissues.

UR - http://www.scopus.com/inward/record.url?scp=85060936331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060936331&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000002099

DO - 10.1097/QAD.0000000000002099

M3 - Article

VL - 33

SP - 411

EP - 423

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 3

ER -